ATE11134T1 - 1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents

1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Info

Publication number
ATE11134T1
ATE11134T1 AT82104398T AT82104398T ATE11134T1 AT E11134 T1 ATE11134 T1 AT E11134T1 AT 82104398 T AT82104398 T AT 82104398T AT 82104398 T AT82104398 T AT 82104398T AT E11134 T1 ATE11134 T1 AT E11134T1
Authority
AT
Austria
Prior art keywords
pyridinyl
piperazine
halogen
preparation
medications containing
Prior art date
Application number
AT82104398T
Other languages
English (en)
Inventor
Walfred S. Saari
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE11134T1 publication Critical patent/ATE11134T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT82104398T 1981-05-26 1982-05-19 1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. ATE11134T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26712081A 1981-05-26 1981-05-26
EP82104398A EP0065757B1 (de) 1981-05-26 1982-05-19 1-(3-Halogen-2-pyridinyl)piperazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE11134T1 true ATE11134T1 (de) 1985-01-15

Family

ID=23017399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82104398T ATE11134T1 (de) 1981-05-26 1982-05-19 1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Country Status (17)

Country Link
EP (1) EP0065757B1 (de)
JP (1) JPS6055068B2 (de)
AT (1) ATE11134T1 (de)
AU (1) AU547319B2 (de)
CA (1) CA1214467A (de)
DE (1) DE3261827D1 (de)
DK (1) DK234282A (de)
ES (4) ES512533A0 (de)
FI (1) FI821739A0 (de)
GR (1) GR76413B (de)
IE (1) IE53035B1 (de)
IL (1) IL65802A (de)
NO (1) NO821730L (de)
NZ (1) NZ200642A (de)
PH (1) PH18686A (de)
PT (1) PT74926B (de)
ZA (1) ZA823611B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH056685U (ja) * 1991-07-09 1993-01-29 株式会社ユアサコーポレーシヨン 電池の艤装構造
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
CN101671297B (zh) * 2008-09-11 2012-05-09 上海药明康德新药开发有限公司 4-(3-碘-2-吡啶基)哌嗪类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773951A (en) * 1972-12-21 1973-11-20 Miles Lab Method of treating depression with 1-(2-pyridyl)piperazine
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines

Also Published As

Publication number Publication date
ES8403476A1 (es) 1984-03-16
ES8403475A1 (es) 1984-03-16
PH18686A (en) 1985-08-29
FI821739A0 (fi) 1982-05-17
AU547319B2 (en) 1985-10-17
IL65802A0 (en) 1982-08-31
ES8306740A1 (es) 1983-06-01
JPS6055068B2 (ja) 1985-12-03
ZA823611B (en) 1983-12-28
IE821225L (en) 1982-11-26
JPS584766A (ja) 1983-01-11
ES519854A0 (es) 1984-03-16
ES512533A0 (es) 1983-06-01
NO821730L (no) 1982-11-29
EP0065757A1 (de) 1982-12-01
DE3261827D1 (en) 1985-02-21
ES519856A0 (es) 1984-03-16
DK234282A (da) 1982-11-27
PT74926B (en) 1985-05-16
AU8380282A (en) 1982-12-02
EP0065757B1 (de) 1985-01-09
ES8403477A1 (es) 1984-03-16
GR76413B (de) 1984-08-10
PT74926A (en) 1982-06-01
CA1214467A (en) 1986-11-25
IE53035B1 (en) 1988-05-11
IL65802A (en) 1985-12-31
NZ200642A (en) 1984-11-09
ES519855A0 (es) 1984-03-16

Similar Documents

Publication Publication Date Title
ATE58534T1 (de) 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3381772D1 (de) Substituierte azabicyclo-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3868076D1 (de) Heterocyclische derivate, verfahren zu ihrer herstellung und diese derivate als aktive bestandteile enthaltende fungizide.
ATE113585T1 (de) Aminsäure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE58904674D1 (de) 4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt.
DE3781195D1 (de) Substituierte benzamidderivate, verfahren zu deren herstellung und diese enthaltende medikamente.
DE3784401D1 (de) Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung.
ATE11134T1 (de) 1-(3-halogen-2-pyridinyl)piperazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE36701T1 (de) Spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
PT77238A (de) Substituierte tert.-butanol-derivate verfahren zu ihrer herstellung und diese enthaltende antimykotische mittel
DE3773240D1 (de) Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
DE3887626D1 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zu deren Herstellung.
ATE75734T1 (de) 1-benzensulfonyl-2-oxo-5-alkoxypyrrolidine, verfahren zu deren herstellung und deren anwendung als heilmittel sowie diese enthaltende zusammenstellungen.
ATE60573T1 (de) Phenylethylamine, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
ATE56950T1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE18550T1 (de) Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
ATE59034T1 (de) Pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen.
ATE58897T1 (de) Pyrimidin-derivate, verfahren zu deren herstellung und diese enthaltende zusammenstellungen.
ATE53992T1 (de) Derivate der cis, endo-2-azabicyclo-(3.3.0>-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
ATE71942T1 (de) Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
ATE12640T1 (de) Imidazolin-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zusammensetzungen und ihre verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee